161 related articles for article (PubMed ID: 12672268)
1. 44th annual meeting of the American Society of Hematology. December 7-10, 2002: Philadelphia, Pennsylvania. Short-course chemotherapy without radiation therapy could be sufficient for elderly patients with localized aggressive non-Hodgkin's lymphoma.
D'Orazio A; Johnson L
Clin Lymphoma; 2003 Mar; 3(4):203-8. PubMed ID: 12672268
[No Abstract] [Full Text] [Related]
2. 42nd Annual Meeting of American Society of Hematology. San Francisco, CA. December 1-5, 2000.
D'Orazio AI; Gambill BD
Clin Lymphoma; 2001 Mar; 1(4):251-6. PubMed ID: 11715982
[No Abstract] [Full Text] [Related]
3. Report from the 34th annual meeting of the American Society of Hematology, December 4-8, 1992.
Markman M
J Cancer Res Clin Oncol; 1993; 119(11):695-6. PubMed ID: 8349726
[No Abstract] [Full Text] [Related]
4. 44th annual meeting of the American Society of Hematology. December 7-10, 2002. Philadelphia, Pennsylvania.
DeGrendele H; Gibson AD; Hightower M
Clin Lymphoma; 2003 Jun; 4(1):10-5. PubMed ID: 12837148
[No Abstract] [Full Text] [Related]
5. Iodine-131 Tositumomab(Bexxar) in relapsed/refractory non-Hodgkin's lymphoma: update from the 2001 American Society of Hematology meeting.
Gibson A
Clin Lymphoma; 2002 Mar; 2(4):209-11. PubMed ID: 11970759
[No Abstract] [Full Text] [Related]
6. [Combination chemotherapy and synchronization therapy in lymphogranulomatosis and non-Hodgkin's lymphomas].
Klein HO
Hamatol Bluttransfus; 1976; 18():135-45. PubMed ID: 786808
[No Abstract] [Full Text] [Related]
7. Early therapy monitoring with FDG-PET in aggressive non-Hodgkin's lymphoma and Hodgkin's lymphoma.
Torizuka T; Nakamura F; Kanno T; Futatsubashi M; Yoshikawa E; Okada H; Kobayashi M; Ouchi Y
Eur J Nucl Med Mol Imaging; 2004 Jan; 31(1):22-8. PubMed ID: 14574514
[TBL] [Abstract][Full Text] [Related]
8. Another summer of hematology.
Ashforth E; Cheson BD
Clin Adv Hematol Oncol; 2010 Aug; 8(8 Suppl 16):1-19. PubMed ID: 21280260
[No Abstract] [Full Text] [Related]
9. A multicenter phase II study of darinaparsin in relapsed or refractory Hodgkin's and non-Hodgkin's lymphoma.
Hosein PJ; Craig MD; Tallman MS; Boccia RV; Hamilton BL; Lewis JJ; Lossos IS
Am J Hematol; 2012 Jan; 87(1):111-4. PubMed ID: 22081459
[No Abstract] [Full Text] [Related]
10. Advances in the treatment of non-Hodgkin lymphoma: interleukin-2 fusion toxin. A review of selected abstracts from the 2004 Annual Meeting of the American Society of Hematology. December 4-7, 2004, San Diego, California.
Clin Adv Hematol Oncol; 2005 Mar; 3(3 Suppl 2):1-5; discussion 6-7. PubMed ID: 21434476
[No Abstract] [Full Text] [Related]
11. Chemotherapy for Hodgkin's disease and aggressive non-Hodgkin's lymphoma. More is better, or is it?
Dodwell DJ; de Campos ES; Radford JA
Drugs; 1992 Jul; 44(1):1-8. PubMed ID: 1379906
[No Abstract] [Full Text] [Related]
12. Bone marrow transplantation for Hodgkin's disease and lymphoma.
Vose JM; Armitage JO
Annu Rev Med; 1993; 44():255-63. PubMed ID: 8476247
[TBL] [Abstract][Full Text] [Related]
13. Advances in chemotherapy for Hodgkin's and non-Hodgkin's lymphomas.
Semin Hematol; 1988 Apr; 25(2 Suppl 2):1-73. PubMed ID: 3399906
[No Abstract] [Full Text] [Related]
14. 56th American Society of Hematology Annual Meeting.
Smith LL
Lancet Oncol; 2015 Jan; 16(1):19-20. PubMed ID: 25524802
[No Abstract] [Full Text] [Related]
15. [Our experience in the treatment of Hodgkin's disease and other reticulopathies with Ro4-6467 (Natulan)].
Arroyo de la Fuente F; Lasheras Garde J; Triginer Boixeda J
Sangre (Barc); 1966; 11(3):265-70. PubMed ID: 6012465
[No Abstract] [Full Text] [Related]
16. Meeting highlights 46th annual meeting of the American Society of Hematology December 2004 San Diego, California.
Price N; Reddy GK; Jain VK
Clin Lymphoma; 2004 Dec; 5(3):144-8. PubMed ID: 15636687
[No Abstract] [Full Text] [Related]
17. Procarbazine (Natulan) in the treatment of Hodgkin's disease and other lymphomas.
Spies SK; Snyman HW
S Afr Med J; 1966 Dec; 40(44):1061-4. PubMed ID: 5334208
[No Abstract] [Full Text] [Related]
18. Radiotherapy as salvage treatment in patients with Hodgkin's disease or non-Hodgkin's lymphoma relapsing after initial chemotherapy.
Kirkove C; Timothy AR
Hematol Oncol; 1991; 9(3):163-7. PubMed ID: 1937407
[TBL] [Abstract][Full Text] [Related]
19. Use of a methyl hydrazine derivative (natulan), especially in Hodgkin's disease.
Hansen MM; Hertz H; Videaek A
Acta Med Scand; 1966 Aug; 180(2):211-24. PubMed ID: 5329155
[No Abstract] [Full Text] [Related]
20. FDG-PET/CT predicts outcome in patients with aggressive non-Hodgkin's lymphoma and Hodgkin's disease.
Querellou S; Valette F; Bodet-Milin C; Oudoux A; Carlier T; Harousseau JL; Chatal JF; Couturier O
Ann Hematol; 2006 Nov; 85(11):759-67. PubMed ID: 16871391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
